Skip to search formSkip to main contentSkip to account menu

propentofylline

Known as: 1-(5'-oxohexyl)-3-methyl-7-propylxanthine, 3,7-Dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-1H-purine-2,6-dione, 1H-Purine-2,6-dione, 3,7-dihydro-3-methyl-1-(5-oxohexyl)-7-propyl- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
s presented at the ESVONC spring meeting, Cambridge, UK, 23–25 March 2007 Veterinary and Comparative Oncology is pleased to… 
2000
2000
In this study, we tested the effects and mechanisms of propentofylline on human neutrophils. The neutrophils were stimulated by… 
1999
1999
Summary: The neuroprotective glial cell modulator propentofylline has been used in clinical trials involving more than 800… 
Review
1997
Review
1997
Dementia belongs to the most serious sociomedical problems of the aging society in the industrialized countries; however, despite… 
1997
1997
Dementia is a syndrome characterized by progressive deterioration in intellectual capacity and other mental functions. The most… 
1994
1994
The effects of the following drugs: nimodipine (1 mg/kg b. w., i. p.), 2-amino-5-phosphonovaleric acid (4mg/kg b.w., i.p.) and… 
1990
1990
The new xanthine derivative propentofylline (3‐methyl‐1‐[5′‐oxohexyl]‐7‐propylxanthine), administered intraperitoneally in a dose… 
1988
1988
We took profit in this work of the discovery of a novel series of trialkylxanthines, with a biological activity greater than that… 
1985
1985
1-(5'-Oxohexyl)-3-methyl-7-propylxanthine (propentofylline), a vasoactive agent, was investigated for its in vitro and in vivo… 
1981
1981
The effects of the xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propylxanthine (HWA 285) (0.5 mg/kg plus 50 micrograms/kg/min i…